Qi, Mengxin
Yi, Xianglan
Yue, Baohui
Huang, Mingxiang
Zhou, Sheng
Xiong, Jing
Funding for this research was provided by:
National Natural Science Foundation of China (NO.81874117, NO.81974419)
Article History
Received: 15 November 2022
Accepted: 10 May 2023
First Online: 22 May 2023
Declarations
:
: This study of xenograft modal was approved by the Institutional Animal Care and Use Committee, Huazhong University of Science and Technology, and was performed in accordance with the National Advisory Committee for Laboratory Animal Research (NACLAR) Guidelines (IACUC Number: 2928). In addition, the study of patients conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (TJ-IRB20210924).
: Authors report no conflicts of interests.